166 related articles for article (PubMed ID: 15816793)
1. Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study.
Toren P; Weizman A; Ratner S; Cohen D; Laor N
J Clin Psychiatry; 2005 Apr; 66(4):499-503. PubMed ID: 15816793
[TBL] [Abstract][Full Text] [Related]
2. Ondansetron treatment in patients with Tourette's syndrome.
Toren P; Laor N; Cohen DJ; Wolmer L; Weizman A
Int Clin Psychopharmacol; 1999 Nov; 14(6):373-6. PubMed ID: 10565805
[TBL] [Abstract][Full Text] [Related]
3. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.
Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R
J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474
[TBL] [Abstract][Full Text] [Related]
6. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
Sallee FR; Nesbitt L; Jackson C; Sine L; Sethuraman G
Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
[TBL] [Abstract][Full Text] [Related]
7. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
[TBL] [Abstract][Full Text] [Related]
11. A Phase-2 Pilot Study of a Therapeutic Combination of Δ
Bloch MH; Landeros-Weisenberger A; Johnson JA; Leckman JF
J Neuropsychiatry Clin Neurosci; 2021; 33(4):328-336. PubMed ID: 34340527
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.
Silver AA; Shytle RD; Sheehan KH; Sheehan DV; Ramos A; Sanberg PR
J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1103-10. PubMed ID: 11556635
[TBL] [Abstract][Full Text] [Related]
13. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.
Welter ML; Houeto JL; Thobois S; Bataille B; Guenot M; Worbe Y; Hartmann A; Czernecki V; Bardinet E; Yelnik J; du Montcel ST; Agid Y; Vidailhet M; Cornu P; Tanguy A; Ansquer S; Jaafari N; Poulet E; Serra G; Burbaud P; Cuny E; Aouizerate B; Pollak P; Chabardes S; Polosan M; Borg M; Fontaine D; Giordana B; Raoul S; Rouaud T; Sauvaget A; Jalenques I; Karachi C; Mallet L;
Lancet Neurol; 2017 Aug; 16(8):610-619. PubMed ID: 28645853
[TBL] [Abstract][Full Text] [Related]
14. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.
Gilbert DL; Sethuraman G; Sine L; Peters S; Sallee FR
Neurology; 2000 Mar; 54(6):1310-5. PubMed ID: 10746603
[TBL] [Abstract][Full Text] [Related]
15. Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study.
Sharafkhah M; Aghakarim Alamdar M; Massoudifar A; Abdolrazaghnejad A; Ebrahimi-Monfared M; Saber R; Mohammadbeigi A
Int Clin Psychopharmacol; 2019 Sep; 34(5):222-233. PubMed ID: 31058716
[TBL] [Abstract][Full Text] [Related]
16. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome.
Leckman JF; Walker DE; Goodman WK; Pauls DL; Cohen DJ
Am J Psychiatry; 1994 May; 151(5):675-80. PubMed ID: 8166308
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
18. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
Budman CL; Gayer A; Lesser M; Shi Q; Bruun RD
J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.
Hoekstra PJ; Minderaa RB; Kallenberg CG
J Clin Psychiatry; 2004 Apr; 65(4):537-42. PubMed ID: 15119917
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.
Kurlan R; Crespi G; Coffey B; Mueller-Vahl K; Koval S; Wunderlich G;
Mov Disord; 2012 May; 27(6):775-8. PubMed ID: 22407510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
